Journal of China Pharmaceutical University Publishing Language: Chinese Open Access Editor-in-Chief: WANG Guang-Ji
Volume 57 Issue 4, August 2026
PP. 411-550
|
15 articles
|
Next Issue
Column Commentary
Column Commentary | Open Access
Antiviral research and drug development targeting the solute carrier superfamily (SLCs)
Published: 25 August 2026
2026, 57(4): 411-421
Column Commentary | Open Access
Structural basis of heteromeric amino acid transporters and advances in targeted drug development
Published: 25 August 2026
2026, 57(4): 422-433
Column Commentary | Open Access
Hepatic cell-specific expression patterns, molecular mechanisms, and therapeutic targeting strategies of solute carrier transporters in drug-induced liver injury
Published: 25 August 2026
2026, 57(4): 434-442
Column Commentary | Open Access
Roles and research progress of the SLC13A5-driven metabolic-inflammatory axis in metabolic diseases, cancers and neurological disorders
Published: 25 August 2026
2026, 57(4): 443-452
Original Article
Original Article | Open Access
Synthesis and antidiabetic activity evaluation of benzopyrimidine-7-azaindole derivatives targeting TXNIP/DYRK1A
Published: 25 August 2026
2026, 57(4): 453-459
Original Article | Open Access
Research on the transformation of diisopropyl azodicarboxylate (DIAD) in gas chromatography and the development of its residual determination method
Published: 25 August 2026
2026, 57(4): 460-465
Original Article | Open Access
Mitophagy-mediated inhibition of glioma proliferation by cannabidiol-loaded hybrid exosomal vesicles
Published: 25 August 2026
2026, 57(4): 466-478
Original Article | Open Access
Xuanbi Xuanfuhua Decoction intervenes in pulmonary source sepsis in rats by regulating PANapoptosis-related proteins
Published: 25 August 2026
2026, 57(4): 479-489
Original Article | Open Access
Investigation of the mechanisms underlying the anti-atherosclerotic effects of Tianxiangdan Capsules through inhibition of pyroptosis via the GPER/NLRP3 pathway
Published: 25 August 2026
2026, 57(4): 490-497
Original Article | Open Access
Establishment of a zebrafish migraine model and pharmacodynamic evaluation of Tianshu Capsules
Published: 25 August 2026
2026, 57(4): 498-504
Original Article | Open Access
Therapeutic efficacy of Xiao’er Guangpu Zhixie Oral Liquid against bacterial diarrhea
Published: 25 August 2026
2026, 57(4): 505-515
Original Article | Open Access
Knowledge graph prediction and molecular docking validation of drug repositioning candidates for hepatic fibrosis
Published: 25 August 2026
2026, 57(4): 516-524
Review
Review | Open Access
Virus-like particles and their applications in the treatment of rare diseases
Published: 25 August 2026
2026, 57(4): 525-533
Invited Article
Invited Article | Open Access
Recent progress in China’s radiopharmaceuticals
Published: 25 August 2026
2026, 57(4): 534-539
Invited Article | Open Access
Advances in research on methods and applications of AI-based drug design in China
Published: 25 August 2026
2026, 57(4): 540-550